 Serotonin Uptake Inhibitors
"Serotonin Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
| Descriptor ID |
D017367
|
| MeSH Number(s) |
D27.505.519.562.437.850 D27.505.519.625.600.850 D27.505.519.625.850.900 D27.505.696.577.600.850 D27.505.696.577.850.900
|
| Concept/Terms |
Serotonin Uptake Inhibitors- Serotonin Uptake Inhibitors
- 5-Hydroxytryptamine Uptake Inhibitors
- 5 Hydroxytryptamine Uptake Inhibitors
- Inhibitors, 5-HT Uptake
- Inhibitors, 5 HT Uptake
- Inhibitors, 5-Hydroxytryptamine Uptake
- Inhibitors, 5 Hydroxytryptamine Uptake
- Inhibitors, Serotonin Reuptake
- Reuptake Inhibitors, Serotonin
- Serotonin Reuptake Inhibitors
- Uptake Inhibitors, 5-HT
- Uptake Inhibitors, 5 HT
- Uptake Inhibitors, 5-Hydroxytryptamine
- Uptake Inhibitors, 5 Hydroxytryptamine
- Uptake Inhibitors, Serotonin
- 5-HT Uptake Inhibitors
- 5 HT Uptake Inhibitors
- Inhibitors, Serotonin Uptake
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Uptake Inhibitors".
This graph shows the total number of publications written about "Serotonin Uptake Inhibitors" by people in this website by year, and whether "Serotonin Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 2 | 0 | 2 | | 2001 | 1 | 0 | 1 | | 2003 | 2 | 1 | 3 | | 2004 | 2 | 0 | 2 | | 2005 | 2 | 0 | 2 | | 2006 | 2 | 1 | 3 | | 2007 | 8 | 1 | 9 | | 2008 | 3 | 2 | 5 | | 2009 | 7 | 2 | 9 | | 2010 | 3 | 2 | 5 | | 2011 | 3 | 1 | 4 | | 2012 | 1 | 0 | 1 | | 2013 | 7 | 3 | 10 | | 2014 | 3 | 6 | 9 | | 2015 | 4 | 1 | 5 | | 2016 | 0 | 1 | 1 | | 2017 | 4 | 2 | 6 | | 2018 | 4 | 1 | 5 | | 2019 | 1 | 1 | 2 | | 2020 | 2 | 2 | 4 | | 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Serotonin Uptake Inhibitors" by people in Profiles.
-
Hunter K, Poel K, Pennington S, Bindseil I, Banerji S, Leonard J, Wang GS. Trends of prescription psychotropic medication exposures in pediatric patients, 2009-2018. Clin Toxicol (Phila). 2022 Feb; 60(2):243-251.
-
Ames JL, Ladd-Acosta C, Fallin MD, Qian Y, Schieve LA, DiGuiseppi C, Lee LC, Kasten EP, Zhou G, Pinto-Martin J, Howerton EM, Eaton CL, Croen LA. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry. 2021 08 15; 90(4):253-262.
-
Payet JM, Wilson KE, Russo AM, Angiolino A, Kavanagh-Ryan W, Kent S, Lowry CA, Hale MW. Involvement of dorsal raphe nucleus serotonergic systems in social approach-avoidance behaviour and in the response to fluoxetine treatment in peri-adolescent female BALB/c mice. Behav Brain Res. 2021 06 25; 408:113268.
-
Czaja AS, Anderson HD, Ghosh D, Davidson J, Campbell JD, Valuck RJ. Increased Odds of Ventricular Arrhythmias Associated with Selective Serotonin Reuptake Inhibitor Use among the Pediatric and Young Adult Population: A Case-Control Study. J Pediatr. 2020 11; 226:173-178.e8.
-
Ang YS, Kaiser R, Deckersbach T, Almeida J, Phillips ML, Chase HW, Webb CA, Parsey R, Fava M, McGrath P, Weissman M, Adams P, Deldin P, Oquendo MA, McInnis MG, Carmody T, Bruder G, Cooper CM, Chin Fatt CR, Trivedi MH, Pizzagalli DA. Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. Biol Psychiatry. 2020 10 15; 88(8):657-667.
-
Nabbout R, Mistry A, Zuberi S, Villeneuve N, Gil-Nagel A, Sanchez-Carpintero R, Stephani U, Laux L, Wirrell E, Knupp K, Chiron C, Farfel G, Galer BS, Morrison G, Lock M, Agarwal A, Auvin S. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial. JAMA Neurol. 2020 03 01; 77(3):300-308.
-
Ramsteijn AS, JaĊĦarevic E, Houwing DJ, Bale TL, Olivier JD. Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression. Gut Microbes. 2020 07 03; 11(4):735-753.
-
Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, Devinsky O, Cross JH, Guerrini R, Talwar D, Miller I, Farfel G, Galer BS, Gammaitoni A, Mistry A, Morrison G, Lock M, Agarwal A, Lai WW, Ceulemans B. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2019 12 21; 394(10216):2243-2254.
-
Diaz I, Thurm C, Hall M, Auerbach S, Bearl DW, Dodd DA, Mettler BA, Smith AH, Fuchs DC, Godown J. Disorders of Adjustment, Mood, and Anxiety in Children and Adolescents Undergoing Heart Transplantation and the Association of Ventricular Assist Device Support. J Pediatr. 2020 02; 217:20-24.e1.
-
Zeitler PS. Growth effects of combined psychotropic regimens. J Pediatr. 2018 10; 201:3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|